News
3h
Zacks Investment Research on MSNWall Street Analysts See a 195.05% Upside in Trevi Therapeutics (TRVI): Can the Stock Really Move This High?Shares of Trevi Therapeutics, Inc. (TRVI) have gained 4.1% over the past four weeks to close the last trading session at ...
3h
Zacks Investment Research on MSNWall Street Analysts See a 161.51% Upside in uniQure (QURE): Can the Stock Really Move This High?Qure (QURE) closed the last trading session at $12.81, gaining 32.8% over the past four weeks, but there could be plenty of ...
US stocks dropped as Wall Street braced for a busy day of Big Tech earnings and digested President Trump's latest move on tariffs.
It’s a big shift from less than two weeks ago, when Trump reposted a video claiming he was “crashing the stock market…on ...
TradingView's powerful charting tools are unmatched in the industry, providing deep insights into stock movements. Ziggma offers a comprehensive stock screener that combines fundamental and ...
After a two-year surge of 53%, the stock market has been taken for a wild ride in 2025, driven by uncertainties surrounding ...
1st Source (SRCE) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of ...
Betting on GameStop has become more than just an act of investing; for many, to invest is to join a movement against the ... GameStop is not a conventional stock. Since the beginning of the ...
AdaptHealth Corp. (AHCO) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results